|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moir J, White SA, French JJ, Littler P and
Manas DM: Systematic review of irreversible electroporation in the
treatment of advanced pancreatic cancer. Eur J Surg Oncol.
40:1598–1604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burkey MD, Feirman S, Wang H, Choudhury
SR, Grover S and Johnston FM: The association between smokeless
tobacco use and pancreatic adenocarcinoma: A systematic review.
Cancer Epidemiol. 38:647–653. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hou BH, Jian ZX, Cui P, Li SJ, Tian RQ and
Ou JR: miR-216a may inhibit pancreatic tumor growth by targeting
JAK2. FEBS Lett. 589:2224–2232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang C and Xie K: Analysis of the
potential for pancreatic cancer metastasis in vitro and in vivo.
Methods Mol Biol. 980:301–319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su D, Yamaguchi K and Tanaka M: The
characteristics of disseminated tumor cells in pancreatic cancer: A
black box needs to be explored. Pancreatology. 5:316–324. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qin Y, Dang X, Li W and Ma Q: miR-133a
functions as a tumor suppressor and directly targets FSCN1 in
pancreatic cancer. Oncol Res. 21:353–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Y, Ou Y, Wu K, Chen Y and Sun W:
miR-143 inhibits the metastasis of pancreatic cancer and an
associated signaling pathway. Tumour Biol. 33:1863–1870. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tréhoux S, Lahdaoui F, Delpu Y, Renaud F,
Leteurtre E, Torrisani J, Jonckheer N and Van Seuningen I:
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by
targeting the MUC1 mucin in pancreatic cancer cells. Biochim
Biophys Acta. 1853:2392–2403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guled M and Knuutila S: MicroRNAs and
cancer. Duodecim. 129:1661–1669. 2013.(In Finnish). PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He Z, Xia Y, Pan C, Ma T, Liu B, Wang J,
Chen L and Chen Y: Up-regulation of miR-452 inhibits metastasis of
non-small cell lung cancer by regulating BMI1. Cell Physiol
Biochem. 37:387–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu Q, Gong JP, Li J, Zhong SL, Chen WX,
Zhang JY, Ma TF, Ji H, Lv MM, Zhao JH and Tang JH: Down-regulation
of miRNA-452 is associated with adriamycin-resistance in breast
cancer cells. Asian Pac J Cancer Prev. 15:5137–5142. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puerta-Gil P, Garcia-Baquero R, Jia AY,
Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava
F and Sánchez-Carbayo M: miR-143, miR-222, and miR-452 are useful
as tumor stratification and noninvasive diagnostic biomarkers for
bladder cancer. Am J Pathol. 180:1808–1815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng Q, Sheng Q, Jiang C, Shu J, Chen J,
Nie Z, Lv Z and Zhang Y: MicroRNA-452 promotes tumorigenesis in
hepatocellular carcinoma by targeting cyclin-dependent kinase
inhibitor 1B. Mol Cell Biochem. 389:187–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Link KH, Leder G, Formentini A, Fortnagel
G, Kornmann M, Schatz M and Beger HG: Surgery and multimodal
treatments in pancreatic cancer-a review on the basis of future
multimodal treatment concepts. Gan To Kagaku Ryoho. 26:10–40.
1999.PubMed/NCBI
|
|
21
|
Vychytilova-Faltejskova P, Kiss I, Klusova
S, Hlavsa J, Prochazka V, Kala Z, Mazanec J, Hausnerova J, Kren L,
Hermanova M, et al: miR-21, miR-34a, miR-198 and miR-217 as
diagnostic and prognostic biomarkers for chronic pancreatitis and
pancreatic ductal adenocarcinoma. Diagn Pathol. 10:382015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Osada H and Takahashi T: MicroRNAs in
biological processes and carcinogenesis. Carcinogenesis. 28:2–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yonemori K, Kurahara H, Maemura K and
Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. 62:33–40.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu M, Xu Z, Wang K, Wang N and Li Y:
microRNA and gene networks in human pancreatic cancer. Oncol Lett.
6:1133–1139. 2013.PubMed/NCBI
|
|
25
|
Liu L, Chen K, Wu J, Shi L, Hu B, Cheng S,
Li M and Song L: Downregulation of miR-452 promotes stem-like
traits and tumorigenicity of gliomas. Clin Cancer Res.
19:3429–3438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ,
Wang TY, Li HC and Wu XN: Differential expression of miRNAs in
esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013.PubMed/NCBI
|
|
27
|
Veerla S, Lindgren D, Kvist A, Frigyesi A,
Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, et
al: miRNA expression in urothelial carcinomas: Important roles of
miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and
metastasis and frequent homozygous losses of miR-31. Int J Cancer.
124:2236–2242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van Lohuizen M, Verbeek S, Scheijen B,
Wientjens E, van der Gulden H and Berns A: Identification of
cooperating oncogenes in E mu-myc transgenic mice by provirus
tagging. Cell. 65:737–752. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong D, Ye Y, Fu Y and Wang J, Kuang B,
Wang H, Wang X, Zu L, Xiao G, Hao M and Wang J: Bmi-1 expression
modulates non-small cell lung cancer progression. Cancer Biol Ther.
16:756–763. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wolters T, Vissers KJ, Bangma CH, Schröder
FH and van Leenders GJ: The value of EZH2, p27(kip1), BMI-1 and
MIB-1 on biopsy specimens with low-risk prostate cancer in
selecting men with significant prostate cancer at prostatectomy.
BJU Int. 106:280–286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang X, Yang X, Zhang Y, Liu X, Zheng G,
Yang Y, Wang L, Du L and Wang C: Direct serum assay for cell-free
bmi-1 mRNA and its potential diagnostic and prognostic value for
colorectal cancer. Clin Cancer Res. 21:1225–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park IK, Morrison SJ and Clarke MF: Bmi1,
stem cells, and senescence regulation. J Clin Invest. 113:175–179.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee K, Adhikary G, Balasubramanian S,
Gopalakrishnan R, McCormick T, Dimri GP, Eckert RL and Rorke EA:
Expression of Bmi-1 in epidermis enhances cell survival by altering
cell cycle regulatory protein expression and inhibiting apoptosis.
J Invest Dermatol. 128:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pasini D, Bracken AP and Helin K: Polycomb
group proteins in cell cycle progression and cancer. Cell Cycle.
3:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song W, Tao K, Li H, Jin C, Song Z, Li J,
Shi H, Li X, Dang Z and Dou K: Bmi-1 is related to proliferation,
survival and poor prognosis in pancreatic cancer. Cancer Sci.
101:1754–1760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yin T, Wei H, Leng Z, Yang Z, Gou S, Wu H,
Zhao G, Hu X and Wang C: Bmi-1 promotes the chemoresistance,
invasion and tumorigenesis of pancreatic cancer cells.
Chemotherapy. 57:488–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
